Higher risk of hypertension in indigenous type 2 diabetic patients in Taiwan

被引:15
|
作者
Tseng, Chin-Hsiao
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan
[3] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan
[4] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Taipei, Taiwan
关键词
blood pressure; Han ethnicity; hypertension; indigenous people; type 2 diabetes mellitus; Taiwan;
D O I
10.1097/01.hjh.0000242406.76085.c4
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: This study compared the risk of hypertension between indigenous and Han adults with type 2 diabetes mellitus (T2DM) in Taiwan. Methods: The data of 89 857 (747 indigenous and 89 110 Han people) T2DM patients aged >= 18 years were extracted from an established cohort of 93 484 diabetic patients using the National Health Insurance system of Taiwan. The prevalence of hypertension before diabetes diagnosis and at the time of survey, and the incidence of hypertension after diabetes diagnosis were compared between the two ethnicities. Results: The indigenous people had a higher prevalence of hypertension before diabetes diagnosis (39.0% versus 29.4%, P < 0.001) and at the time of survey (66.9% versus 54.4%, P < 0.001); and showed poorer blood pressure control, with systolic pressure >= 140 mmHg (38.4% versus 30.3%, P < 0.001) and diastolic pressure >= 90 mmHg (20.4% versus 15.5%, P < 0.001). Logistic and Cox's regression models showed an adjusted risk of hypertension of about twofold in indigenous people compared to the Han people. Conclusions: The indigenous diabetics are more prone to develop hypertension than their Han counterparts in Taiwan.
引用
收藏
页码:1817 / 1821
页数:5
相关论文
共 50 条
  • [41] Population pharmacokinetic analysis of bisoprolol in type 2 diabetic patients with hypertension
    Momcilovic, Stefan
    Jovanovic, Andriana
    Radojkovic, Danijela
    Nikolic, Valentina N.
    Jankovic, Slobodan M.
    Pesic, Milica
    Milovanovic, Jasmina R.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (11) : 1539 - 1546
  • [42] KNOWLEDGE ASSESMENT OF DIABETES AND INCIDENCE OF HYPERTENSION IN TYPE 2 DIABETIC PATIENTS
    Adnan, Rao Muhammad
    Hassan, Muhammad Shahbaz
    Arif, Muhammad
    Khan, Muhammad Zahid
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (12): : 16080 - 16087
  • [43] Tramadol is a risk factor for hypoglycemia in diabetic patients in Taiwan
    Chen, Hsin Hung
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S196 - S196
  • [44] Prevalence and distinguishing features of masked hypertension in type 2 diabetic patients
    Zhou, Jianguang
    Liu, Changyun
    Shan, Peijia
    Zhou, Yingqi
    Xu, Erli
    Ji, Yufeng
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2013, 27 (01) : 82 - 86
  • [45] Effect of essential hypertension on endothelial function in type 2 diabetic patients
    Natali, A
    Toschi, E
    Sironi, A
    Camastra, S
    Ferrannini, E
    DIABETES, 2001, 50 : A161 - A162
  • [46] Population pharmacokinetic analysis of bisoprolol in type 2 diabetic patients with hypertension
    Stefan Momčilović
    Andriana Jovanović
    Danijela Radojković
    Valentina N. Nikolić
    Slobodan M. Janković
    Milica Pešić
    Jasmina R. Milovanović
    European Journal of Clinical Pharmacology, 2020, 76 : 1539 - 1546
  • [47] The prognostic value of masked hypertension in type 2 normotensive diabetic patients
    Abdul-Rahman, S. M.
    Taha, A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 448 - 448
  • [49] CARDIOVASCULAR OUTCOME OF DIASTOLIC ORTHOSTATIC HYPERTENSION IN TYPE 2 DIABETIC PATIENTS
    Li, Wen
    Li, Gang
    JOURNAL OF HYPERTENSION, 2018, 36 : E118 - E118
  • [50] Microalbuminuria and diabetic retinopathy in type 2 diabetic patients: From risk association to risk prediction
    Chang, Chia-Hsuin
    Chuang, Lee-Ming
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (01) : 42 - 44